Delivery Order SPE2DX22D0059-SPE2D825F0HTA
- Not listed
- This delivery order, awarded August 12, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order carries a ceiling value of $11,262.65 under firm fixed-price terms and is non-set-aside, competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as...
- This delivery order, awarded on August 4, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery order carries a ceiling value of $10,473.58 with firm fixed pricing and is scheduled for completion by August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- This delivery order, awarded on July 31, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX. The order carries a ceiling value of $37,117.83 under firm fixed pricing and is scheduled for completion by August 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through competitive...
- This delivery order, awarded on July 21, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order carries a ceiling value of $11,112.69 and employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- This delivery order, awarded July 21, 2025, represents a $4,038.72 firm fixed-price contract issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and was competitively awarded, is a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The order is scheduled for ultimate completion on July 22, 2025,...
- This delivery order, awarded on July 28, 2025, to AmerisourceBergen Drug Corp under contract 4568908378, is valued at $17,086.56 with a firm fixed price structure and an ultimate completion date of July 29, 2025. The award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle...
- This delivery order, issued on August 15, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $83,652.14 for pharmaceutical and medical supply provision. The contract is a child award under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The work is to be performed at the company's Corporate Office...
- This delivery order, awarded July 21, 2025, represents a $2,156.05 firm fixed-price contract to AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery to support the Defense Logistics Agency's Medical Supply Chain operations. The contract, which is not set-aside and was competitively awarded, is designated as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December...
- This delivery order, awarded July 29, 2025, represents a $1,037.95 firm fixed price contract issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999.99 million through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply...
- This delivery order, awarded July 30, 2025, to AmerisourceBergen Drug Corp represents a $9,374.82 firm fixed-price contract funded by the Defense Logistics Agency's Medical Supply Chain division. The award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support for military...
- SPE2DX22D0059Indefinite Delivery Contract
- SPE2DX22D0059-SPE2D825F0HTADelivery Order
This delivery order, awarded on July 21, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999,999,999.00. The delivery order carries a ceiling value of $24,697.26 under firm fixed price terms with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was competitively selected without set-aside designation to fulfill this medical procurement requirement for the Defense Logistics Agency's Medical Supply Chain. Performance will occur at the contractor's corporate office location in Conshohocken, PA. The award reflects AmerisourceBergen Drug Corp's established role as a critical federal medical vendor supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs. The company's delivery orders under the SPE2DX prime contract typically encompass a broad spectrum of pharmaceuticals including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order contributes to the Defense Logistics Agency's mission to provide reliable, cost-effective medical supply chain support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning contractors like AmerisourceBergen to continue serving critical federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 7/21/25 |